Core Viewpoint - V2X (VVX) is anticipated to report a year-over-year increase in earnings despite lower revenues, which could significantly influence its near-term stock price depending on how actual results compare to consensus estimates [1][2]. Earnings Expectations - The upcoming earnings report is expected to be released on August 4, with a consensus estimate of $1.00 per share, reflecting a year-over-year increase of +20.5%. Revenues are projected to be $1.04 billion, down 3.1% from the previous year [3][2]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly altered their initial projections during this period [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that V2X has a positive Earnings ESP of +4.17%, suggesting analysts have recently become more optimistic about the company's earnings prospects. However, the stock holds a Zacks Rank of 4, complicating predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, V2X was expected to earn $0.92 per share but exceeded expectations with earnings of $0.98, resulting in a surprise of +6.52%. Over the last four quarters, the company has beaten consensus EPS estimates three times [13][14]. Conclusion - While V2X does not appear to be a strong candidate for an earnings beat, it is essential for investors to consider other factors when making decisions regarding the stock ahead of the earnings release [17].

The market expects Williams Companies, Inc. (The) (WMB) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expect ...

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Atlas Energy Solutions Inc. (AESI) despite higher revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The upcoming earnings report is expected on August 4, with a consensus estimate of $0.14 per share, reflecting a year-over-year decrease of 12.5%. Revenues are projected to be $301.24 million, an increase of 4.8% from the previous year [3]. - The consensus EPS estimate has been revised down by 9.21% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows a positive Earnings ESP of +11.11% for Atlas Energy Solutions, suggesting recent bullish sentiment among analysts [12]. - However, the company holds a Zacks Rank of 5 (Strong Sell), complicating predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, Atlas Energy Solutions was expected to earn $0.18 per share but only achieved $0.08, resulting in a surprise of -55.56% [13]. - The company has not surpassed consensus EPS estimates in any of the last four quarters [14]. Industry Comparison - Cactus, Inc. (WHD), a peer in the oil and gas sector, is expected to report an EPS of $0.67, down 17.3% year-over-year, with revenues projected at $275.61 million, a decrease of 5.1% [18]. - Cactus has a Zacks Rank of 5 and an Earnings ESP of 0%, making it similarly challenging to predict an earnings beat [20].

Core Viewpoint - Ambac Financial Group (AMBC) is expected to report a year-over-year decline in earnings due to lower revenues, with a consensus outlook indicating a quarterly loss of $0.24 per share, representing a -233.3% change from the previous year [1][3]. Earnings Expectations - The upcoming earnings report is crucial for stock movement; better-than-expected results could drive the stock higher, while a miss may lead to a decline [2]. - The consensus estimate for revenues is projected at $55.59 million, down 47.1% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 25% higher in the last 30 days, reflecting a reassessment by analysts [4]. - Ambac's Most Accurate Estimate is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +12.50%, indicating a likelihood of beating the consensus EPS estimate [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a favorable Zacks Rank [10]. - Ambac currently holds a Zacks Rank of 3, which indicates a neutral outlook, but the positive Earnings ESP suggests potential for an earnings surprise [12]. Historical Performance - Ambac has not been able to beat consensus EPS estimates in any of the last four quarters, with the last reported quarter showing a significant miss of -85.71% [13][14]. Industry Comparison - Skyward Specialty Insurance (SKWD), another player in the insurance industry, is expected to report a year-over-year EPS increase of +7.5% and has a positive Earnings ESP of +2.51%, indicating a likely earnings beat [18][19].

Core Insights - S&P Global Inc. (SPGI) is set to release its second-quarter 2025 results on July 31, with a history of surpassing earnings estimates, averaging a surprise of 7.5% over the past four quarters [1][9]. Revenue Expectations - The Zacks Consensus Estimate for SPGI's revenues is $3.7 billion, reflecting a 3.7% increase from the same quarter last year, driven by strong core product demand and effective marketing initiatives [2][10]. - Market Intelligence revenues are projected at $1.2 billion, indicating a 3.7% year-over-year growth, supported by strong data analytics performance and positive M&A contributions [3][10]. - Ratings revenues are estimated at $1.1 billion, slightly above last year's figure, benefiting from increased issuance and refinancing activity [4]. - Commodity Insights revenues are expected to reach $539.8 million, showing a 4.6% year-over-year growth, aided by high demand for data and insights [5]. - Mobility revenues are projected at $420.1 million, reflecting a 5% increase from the previous year, driven by strong demand for CARFAX and effective marketing [6]. - Indices revenues are estimated at $397.2 million, implying a 2.1% year-over-year increase, primarily due to strong asset-linked fee growth [7]. Profitability Metrics - Adjusted EBITDA is estimated at $2.1 billion for the quarter, up 2.5% from the previous year, driven by top-line growth and strategic expense management [8]. - The consensus estimate for earnings per share is $4.25, indicating a 5.2% year-over-year increase, likely supported by margin expansion [8][10]. Earnings Prediction - The model predicts an earnings beat for SPGI, with an Earnings ESP of +0.52% and a Zacks Rank of 2 (Buy), enhancing the likelihood of exceeding earnings expectations [9].

Core Viewpoint - Bristol-Myers Squibb Company (BMY) is set to report its second-quarter 2025 results on July 31, with sales and earnings estimates at $11.38 billion and $1.18 per share, respectively. However, earnings estimates for 2025 and 2026 have seen a decline over the past month [1][5]. Financial Estimates - The current earnings estimate for Q2 2025 is $1.18, down from $1.55 30 days ago, reflecting a decrease of 29.34%. The earnings estimates for 2025 and 2026 have also decreased to $6.37 and $6.03, respectively [2][5]. - BMY has a strong earnings surprise history, beating estimates in the last four quarters with an average surprise of 20.16% [2]. Factors Influencing Q2 Results - Total quarterly revenues are expected to be negatively impacted by declining sales from the legacy portfolio, which includes drugs like Eliquis, Revlimid, and Pomalyst, primarily due to generic competition [4][5]. - Sales for Pomalyst are estimated at $727 million, while Eliquis is projected to generate $3.5 billion in sales [6][7]. Growth Portfolio Performance - The growth portfolio, which includes drugs like Opdivo, Reblozyl, and Camzyos, is expected to partially offset the decline in legacy drug sales. Opdivo sales are estimated at $2.4 billion, while Reblozyl is projected at $546 million [8][10][11]. - New drug Cobenfy for schizophrenia has shown promising sales growth, indicating a positive start for the newly launched product [12][18]. Strategic Initiatives - BMY has announced cost-cutting plans aiming to save $1.5 billion by 2025 and an additional $2 billion annually by 2027, which are expected to improve profitability [5][14]. - The company has entered a strategic collaboration with BioNTech for the co-development of a bispecific antibody, BNT327, which targets solid tumors [19][22]. Stock Performance and Valuation - BMY shares have declined by 14.4% year-to-date, underperforming the industry and the S&P 500 [16]. - The stock currently trades at a price/earnings ratio of 7.84x forward earnings, lower than its historical mean and the large-cap pharma industry average [20].

Core Insights - American Superconductor Corporation (AMSC) is expected to report first-quarter fiscal 2025 results on July 30, with anticipated revenues between $64 million and $68 million, reflecting a 61.7% year-over-year increase from the previous quarter's reported figure of $39.6 million [1][10] - The company forecasts non-GAAP earnings to exceed 10 cents per share, with the consensus estimate at 12 cents per share, indicating a 50% year-over-year increase [2][10] - AMSC has consistently surpassed earnings estimates in the past four quarters, with an average surprise of 241.2% [2] Revenue Drivers - The acquisition of NWL Inc. for $56.4 million in August 2024 is expected to positively impact both top and bottom lines in the first quarter [3] - Improved business model, increased bookings, and a strengthened balance sheet are anticipated to contribute to revenue growth [4] - The Grid segment is projected to generate revenues of $55.6 million, a 71.9% increase year-over-year, driven by rising demand for energy power and ship protection systems [5][10] - The Wind segment is expected to see revenues of $7.6 million, reflecting a 20% year-over-year growth, supported by increased shipments of 2-megawatt and 3-megawatt turbines [6][10] Challenges - Macroeconomic uncertainties and unfavorable foreign exchange fluctuations are noted as potential concerns for the company [7] Earnings Prediction Model - The current model does not predict a definitive earnings beat for AMSC, as it holds a Zacks Rank 4 (Sell) and an Earnings ESP of 0.00% [8][9]

Core Viewpoint - MGM Resorts International is expected to report a decline in both revenues and earnings per share (EPS) for the second quarter of 2025, influenced by softer operational trends and inflationary pressures [1][8]. Estimate Revisions - The Zacks Consensus Estimate for second-quarter EPS has risen to 58 cents from 55 cents, but this reflects a 32.6% decrease from 86 cents in the same quarter last year [2]. - Projected revenues are estimated at nearly $4.3 billion, indicating a slight decline of 0.6% from the previous year's quarter [2]. Factors Influencing Quarterly Results - The decline in MGM's top and bottom lines is attributed to lower casino activity, reduced non-gaming demand, and weaker average daily rates, compounded by ongoing inflation and a tight labor market [3]. - Contributions from casino, rooms, and food and beverage are expected to be lower, with estimates of $2.17 billion, $880 million, and $722 million respectively, compared to $2.21 billion, $899 million, and $802 million from the prior year [4]. Operational Insights - Elevated operating expenses and wage inflation are likely to exert margin pressure, although digital growth, strong Las Vegas operations, and robust group bookings are expected to support performance [5]. - For Las Vegas operations, revenue estimates for casino and rooms are pegged at $500 million and $775 million, respectively, showing growth from $485 million and $767 million in the prior year [6]. - Regional properties are anticipated to generate steady cash flow, with revenue estimates of $702 million and $80 million for casino and rooms, respectively, compared to $684 million and $79 million in the previous year [7]. Earnings Prediction Model - The current model does not predict an earnings beat for MGM Resorts, as the company has an Earnings ESP of -2.80% and a Zacks Rank of 3 (Hold) [9].

Core Viewpoint - Shell plc (SHEL) is expected to report second-quarter results on July 31, with earnings estimated at $1.13 per share and revenues of $73.7 billion, reflecting a significant year-over-year decline in earnings and a slight decrease in revenues [1][3]. Group 1: Q1 Performance and Historical Context - In the previous quarter, Shell reported earnings of $1.84 per ADS, surpassing the Zacks Consensus Estimate of $1.54, but revenues of $70.2 billion fell short by over 12% due to lower LNG sales [2]. - Shell has beaten the Zacks Consensus Estimate for earnings in three of the last four quarters, with an average earnings surprise of 1.7% [3]. Group 2: Factors Influencing Q2 Results - Shell's Integrated Gas division is expected to produce between 900,000 and 940,000 barrels of oil equivalent per day, a decrease from the previous quarter's 927,000 [4][8]. - LNG output is projected to be between 6.4 million and 6.8 million tons, with weaker gas trading results anticipated compared to Q1 [4]. - Traditional drilling production is expected to decline to 1.66-1.76 million barrels of oil equivalent per day due to maintenance and asset sales [4]. Group 3: Refining and Chemicals Outlook - Refining margins have improved, rising from $6.20 per barrel in Q1 to $8.90 per barrel in Q2, supported by better refinery utilization [5][8]. - The chemicals segment is expected to report a loss due to unplanned shutdowns at the Monaca plant, impacting overall quarterly results [5][8]. - The renewables and energy solutions segment's performance is projected to range from a $400 million loss to a $200 million profit [5]. Group 4: Earnings Prediction and Model Insights - The Zacks model indicates uncertainty in Shell's ability to beat earnings estimates for Q2, with an Earnings ESP of 0.00% as both the Most Accurate Estimate and the Zacks Consensus Estimate are at $1.13 per share [6][7][9]. - Shell currently holds a Zacks Rank 3, which does not enhance the predictive power of the Earnings ESP due to the 0.00% figure [9].

Core Insights - Generac Holdings Inc. (GNRC) is set to report its second-quarter 2025 results on July 30, with expected revenues of $1.02 billion, reflecting a 2.6% increase year over year. The consensus estimate for earnings is $1.33 per share, down 1.5% from the previous year [1][7]. Revenue and Earnings Estimates - The Zacks Consensus Estimate for second-quarter revenues is $1.02 billion, which is a 2.6% increase from the prior year's reported figure [1]. - The consensus estimate for earnings per share is $1.33, indicating a 1.5% decline year over year, with a recent downward adjustment of 2 cents in the past week [1][2]. Recent Performance - GNRC has consistently exceeded the Zacks Consensus Estimate in the last four quarters, achieving an average earnings surprise of 15.45%. Over the past year, GNRC shares have increased by 1%, while the Zacks Manufacturing-General Industrial industry has grown by 6.9% [2]. Factors Influencing Q2 Performance - The Residential segment, particularly home standby generators, is expected to be a significant growth driver, with Residential product sales increasing by 15% year over year to $494 million in Q1 2025, driven by rising power outages and demand for reliable backup power solutions [3]. - The adoption of residential-energy technology products, including ecobee and Energy Storage systems, is anticipated to contribute positively to revenue growth. New product launches and investments in manufacturing capacity are also expected to support top-line momentum [4]. Margin Performance - Margin performance is likely to benefit from a favorable sales mix due to strong home standby shipments, improved production efficiencies, and reduced input costs [5]. - However, there are concerns regarding softness in Commercial & Industrial (C&I) sales, which saw a 5% year-over-year decline in Q1 2025, totaling $337 million. Management anticipates flat C&I sales year over year for Q2 [5][8]. Market Conditions - The company faces challenges from volatile macroeconomic conditions, including tariff issues, intense competition, and rising operating costs, particularly due to increased marketing expenditures. For Q2 2025, Residential product sales are expected to show modest growth, with estimates of $557 million, while C&I product revenues are projected at $343 million [9]. Earnings Prediction Model - Current models do not predict an earnings beat for Generac, as the company has an Earnings ESP of -0.19% and a Zacks Rank of 3 (Hold) [10].